{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T07:40:39Z","timestamp":1697960439423},"reference-count":32,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2009,2,5]],"date-time":"2009-02-05T00:00:00Z","timestamp":1233792000000},"content-version":"vor","delay-in-days":7890,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Cardiology"],"published-print":{"date-parts":[[1987,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>In vitro<\/jats:italic> and <jats:italic>in vivo<\/jats:italic> electrophysiological studies have shown that propafenone could be classified as a class I antiarrhythmic agent. The aim of this study was to investigate the short\u2010term antiarrhythmic efficacy and safety of propafenone in 10 patients compared to disopyramide in a double\u2010blind randomized protocol. Included patients suffered from ventricular arrhythmias with at least 60 ventricular premature beats (VPB) per hour refractory to at least two other antiarrhythmic agents. At the end of the control period and of the two treatment periods during which patients received either propafenone (300 mg three times a day) or disopyramide (200 mg three times a day), clinical examination, Holter recordings, electrocardiogram, and clinical laboratory tests were performed. The PR interval and the QRS interval were significantly increased with propafenone, but not with disopyramide. The cQT interval was not significantly changed by either propafenone or disopyramide. Heart rate was decreased with propafenone (p&lt;0.05) with no change in the diurnal\/nocturnal circadian ratio variation. Heart rate was significantly decreased with disopyramide only during the day. Five of nine patients in the propafenone group and two of nine patients in the disopyramide group showed a reduction in ventricular premature beats greater than 80%. Total resolution of severe arrhythmias (repetitive events) was seen in 5 of 8 patients with propafenone; 2 of 8 with disopyramide. Adverse events, when they occurred, were mild (visual disturbances, epigastric discomfort, changes in taste perception, transient atrioventricular block with propafenone, and photophobia with disopyramide), and did not require reduction or discontinuation of study drug. Considering these results, propafenone is expected to be an efficient antiarrhythmic drug in the treatment of severe ventricular arrhythmias.<\/jats:p>","DOI":"10.1002\/clc.4960100707","type":"journal-article","created":{"date-parts":[[2009,2,7]],"date-time":"2009-02-07T03:42:07Z","timestamp":1233978127000},"page":"405-410","source":"Crossref","is-referenced-by-count":2,"title":["Propafenone versus disopyramide: A double\u2010blind randomized crossover trial in patients presenting chronic ventricular arrhythmias"],"prefix":"10.1002","volume":"10","author":[{"given":"C.","family":"Libersa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Caron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pladys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Beuscart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kacet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Wajman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Connell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lekieffre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,2,5]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-68926-0_20"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01003037"},{"key":"e_1_2_1_4_2","first-page":"392","article-title":"Kinetics of the recovery of sodium\u2010channels from the blocking action of antifibrillatory drugs","volume":"266","author":"Liebeswar G","year":"1970","journal-title":"Naunyn\u2010Schmiedebergs Arch Pharmakol"},{"key":"e_1_2_1_5_2","unstructured":"LibersaC CaronJ BechtelP KacetS MarchandX DupuisB LekieffreJ:Interest and limitations of phenotype determination of hydroxylation ability in patients treated with propafenone.Cardiac Prog Electrophysiol Pacing(in press)."},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/17.6.344"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1984.tb01822.x"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198111000-00002"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-68926-0_13"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-68926-0_19"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(83)90575-1"},{"key":"e_1_2_1_12_2","first-page":"1370","article-title":"Effet anti\u2010arythmique de la propafenone per os. A propos de 70 observations","volume":"77","author":"Coumel P","year":"1984","journal-title":"Arch Mal Coeur"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-68926-0_27"},{"key":"e_1_2_1_14_2","first-page":"269","article-title":"Propafenone. An effective anti\u2010arrhythmic agent for ventricular tachycardia","volume":"66","author":"Podrid PJ","year":"1982","journal-title":"Circulation"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(76)80054-3"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-197815050-00002"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-68926-0_28"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-96-3-337"},{"key":"e_1_2_1_19_2","first-page":"774","article-title":"Action antiarhythmique du disopyramide","volume":"72","author":"Page A","year":"1979","journal-title":"Arch Mal Coeur"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(84)90687-8"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.58.3.408"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.61.4.690"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/000331978303400603"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198203000-00017"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(76)90148-3"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(73)90280-9"},{"key":"e_1_2_1_27_2","first-page":"713","article-title":"Zur Antiarrhythmischen Wirksamkeit von Disopyramide bei ventrikularer Extrasystolie und Vorhofflimmen","volume":"65","author":"Breithardt G","year":"1976","journal-title":"Z Kardiol"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.65.5.886"},{"key":"e_1_2_1_29_2","first-page":"903","article-title":"Les effets des anti\u2010arythmiques sur le rythme sinusal. Appr\u00e9eciation gr\u01ceace aux enregistrements ECG de longue dur\u00e9ee quantifi\u00e9es par le syst\u00e9eme ATREC","volume":"73","author":"Leclercq JF","year":"1980","journal-title":"Arch Mal Coeur"},{"key":"e_1_2_1_30_2","first-page":"367","article-title":"Effects of intrinsic sympathetic activity of beta\u2010blockers on SA and AV nodes in man","volume":"12","author":"Leclercq JF","year":"1981","journal-title":"Eur J Cardiol"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-68926-0_11"},{"key":"e_1_2_1_32_2","first-page":"67","article-title":"Efficacy of propafenone for treatment of ventricular ectopic depolarization","volume":"66","author":"Salerno D","year":"1982","journal-title":"Circulation"},{"key":"e_1_2_1_33_2","first-page":"731","article-title":"Elektrophysiologische Effekta der Antiarrhythmika Disopyramide und Propafenone auf das menschliche Reizleitungssystem","volume":"64","author":"Seipel L","year":"1975","journal-title":"Z Kardiol"}],"container-title":["Clinical Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fclc.4960100707","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/clc.4960100707","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T14:50:06Z","timestamp":1697899806000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/clc.4960100707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1987,7]]}},"alternative-id":["10.1002\/clc.4960100707"],"URL":"https:\/\/doi.org\/10.1002\/clc.4960100707","archive":["Portico"],"relation":{},"ISSN":["0160-9289","1932-8737"],"issn-type":[{"value":"0160-9289","type":"print"},{"value":"1932-8737","type":"electronic"}],"subject":[],"published":{"date-parts":[[1987,7]]}}}